High cumulative doses of pegylated liposomal doxorubicin are not associated with cardiac toxicity in patients with gynecologic malignancies

Joshua P. Kesterson, Kunle Odunsi, Shashikant Lele

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'High cumulative doses of pegylated liposomal doxorubicin are not associated with cardiac toxicity in patients with gynecologic malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds